Spurned GSK chief: We’re the ‘compelling owner’ for HGS

Human Genome Sciences ($HGSI) wants to flirt with some new potential suitors. After turning down GlaxoSmithKline's ($GSK) $2.6 billion offer last week, the company says it's exploring its stra…
Read the full story: News